Xyall
Latest round
- Series B
Last raised
- May 2022
Total raised
- $6.4M
Investors
- 3
About Xyall
V. operates as a biotechnology company that supports automation and digitization of the tissue dissection workflow.V. The company integrates precision robotics, digital pathology, and workflow optimization to bridge the gap between histopathology and molecular pathology. Their Tissector solutions offer high accuracy, high throughput, and full quality control. Xyalls flagship products include the Tissector High Throughput (HT), Tissector Table Top (TT) solutions, and Tissector Annotation Suite (AS), designed to cater to the diverse needs of molecular diagnostic laboratories. HT offers continuous operation and is fully integrated with digital pathology solutions (IMS) and laboratory workflow management (LIMS) for high-volume molecular diagnostic laboratories.1 mm and 3 hours of uninterrupted operation time. TT offers batch operation fully integrated with digital pathology solutions and the laboratory workflow (LIMS) for small to medium-sized molecular pathology laboratories.1 mm and of 2 hrs uninterrupted operation time. AS is a digital workstation that allows pathologists to remotely see and annotate cases with over 40 times magnification.
Who invested in Xyall
3 investors across 1 round
See all investors in Xyall
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
May 24, 2022
Amount
$6.4M
Investors
Questions about Xyall
Who invested in Xyall?
Xyall has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xyall raised?
Xyall has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Xyall last raise money?
Xyall's most recent round on record is a Series B, in May 2022.
What does Xyall do?
Xyall is a biotechnology company.
Where is Xyall headquartered?
Xyall is headquartered in Eindhoven, Netherlands.
Which VCs invest in companies like Xyall?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Xyall's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Xyall? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.